Greenwood Way Capital

Power Roll develops proprietary energy storage systems and solar photovoltaic technologies. Its products include supercapacitors, batteries, and ultra-thin flexible solar films produced via a rapid, low-cost process. The company's innovations aim to disrupt various markets by offering significant advantages over existing technologies.

Epipole Ltd. is a UK-based company founded in 2011, specializing in the design and manufacture of advanced retinal imaging devices. The company is best known for its EpiCam product line, which includes several models tailored for different applications. The epiCam M is a handheld digital retinal fundus camera that allows real-time exploration of retinal vasculature, while the epiCam C provides enhanced color imaging beyond traditional desktop cameras. The epiCam V is specifically designed for veterinary use, offering high-quality fundus imaging for animals. Additionally, Epipole produces the Model Eye, an optical replica of the human eye used for training medical students in the use of ophthalmoscopes and fundus cameras. By focusing on image processing and medical imaging technologies, Epipole is disrupting the ophthalmic device space, facilitating early diagnosis and monitoring of retinal diseases such as diabetic retinopathy. The company distributes its products through various channels, including partnerships with distributors and online sales.

Landytech is a software company specializing in the development of advanced platforms for investment reporting and risk analytics tailored for family offices, asset managers, and fiduciaries. The company provides technology that encompasses a wide range of asset classes, including private assets, alternatives, and complex derivatives. Landytech's offerings include automated investment reporting, risk management, and data aggregation, which empower modern investors to effectively analyze their financial positions. By creating sophisticated financial databases and software applications, Landytech enhances risk and regulatory reporting, enabling clients to efficiently process and manage their investment data.

ETA Green Power designs and manufactures electric drive systems, including motors, power controllers, inverters, magnetics, chargers and converters, to replace traditional mechanical and hydraulic drive systems. Building on more than 15 years of research, its technology delivers efficient, high-performance, cost-effective electric propulsion for outdoor power equipment, off-highway vehicles, e-mobility, marine and HVAC applications, enabling manufacturers to accelerate electrification while reducing reliance on hydrocarbons and rare-earth magnets.

Epipole Ltd. is a UK-based company founded in 2011, specializing in the design and manufacture of advanced retinal imaging devices. The company is best known for its EpiCam product line, which includes several models tailored for different applications. The epiCam M is a handheld digital retinal fundus camera that allows real-time exploration of retinal vasculature, while the epiCam C provides enhanced color imaging beyond traditional desktop cameras. The epiCam V is specifically designed for veterinary use, offering high-quality fundus imaging for animals. Additionally, Epipole produces the Model Eye, an optical replica of the human eye used for training medical students in the use of ophthalmoscopes and fundus cameras. By focusing on image processing and medical imaging technologies, Epipole is disrupting the ophthalmic device space, facilitating early diagnosis and monitoring of retinal diseases such as diabetic retinopathy. The company distributes its products through various channels, including partnerships with distributors and online sales.

Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers unique products and collaborative research and development services that aid in the discovery of new cell strains and molecules. Its cell analysis systems facilitate the screening and isolation of rare and valuable biological variants, catering to various applications in research, therapeutic development, bioproduction, and diagnostics. By streamlining these processes, Sphere Fluidics enables clients to reduce costs and time, thereby accelerating advancements in biological and biopharmaceutical discovery.